1. Home
  2. ENRD vs OLMA Comparison

ENRD vs OLMA Comparison

Compare ENRD & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ENRD

Einride AB American Depositary Shares

N/A

Current Price

$4.90

Market Cap

858.4M

Sector

Technology

ML Signal

N/A

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$10.60

Market Cap

949.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENRD
OLMA
Founded
N/A
2006
Country
Sweden
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.4M
949.3M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
ENRD
OLMA
Price
$4.90
$10.60
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$44.89
AVG Volume (30 Days)
152.8K
953.1K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
15.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.63
$5.99
52 Week High
$10.49
$36.26

Technical Indicators

Market Signals
Indicator
ENRD
OLMA
Relative Strength Index (RSI) 38.67 44.14
Support Level $4.69 $9.70
Resistance Level $5.50 $11.36
Average True Range (ATR) 0.68 0.43
MACD -0.08 -0.02
Stochastic Oscillator 3.66 36.43

Price Performance

Historical Comparison
ENRD
OLMA

About ENRD Einride AB American Depositary Shares

Einride AB is a technology company that develops and operates digital, electric, and autonomous freight solutions. Its platform includes planning and optimization tools, autonomous technologies, electric heavy-duty vehicle fleets, and charging infrastructure. It serves customers across North America, Europe, and the Middle East. The company's solutions support customers in transitioning logistics operations to electric and autonomous systems. Its business model includes Freight-Capacity-as-a-Service (FCaaS) and Software-as-a-Service (SaaS) offerings delivered through an AI-based platform that manages aspects of electric and autonomous operations.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: